征稿已开启

查看我的稿件

注册已开启

查看我的门票

已截止
活动简介

ConferenceSeries Ltd would like to take this opportunity to welcome all of you to “8th International Conference on Proteomics & Bioinformatics” which is to be held during May 22-24, 2017 at Osaka, Japan. Through our theme ‘Proteomics & Bioinformatics: Solving Problems in Health and Life Sciences’, the conference will analyze the recent advancements and new modes that can be enforced to the research to take Proteomics, one step further.

Proteomics 2017 conference will impact an attractive moment to meet people in the research field and therefore it takes a delight in opening a gate to meet the ability in the field, young researchers and potential speakers. The conference also includes essential topics on Protein Expression and Analysis, Database, Mass Spectrometry, Proteomics Discovery And Function, Analytical Proteomics and Genomics, Protein Biochemistry, Personalized Medicine In Proteomics, Cardiovascular Proteomics, Computational and Biology Proteomics, Proteomics for Bioinformatics, Plant Proteomics, Food and Nutritional Proteomics, Cancer and Clinical proteomics, Immunoproteomics, Protein Engineering and Molecular Design, Neuroproteomics & Neurometabolomics and many more.

ConferenceSeries Ltd coordinates 1000+ Global events. Every Year across USA, Europe and Asia with backing from 1000 more scientific societies & Publishes 700+ Open access journals which encompass over 100000 eminent personalities, reputed scientists as an editorial board & organizing committee members. ConferenceSeries Ltd is recognized by International Congress as well as Convention Association. World Congress and also International conference as momentously captivated by Nobel laureates, International Symposiums & Workshops, Keynote gatherings, Exhibitions and Delegates.

Hence, we welcome you all to be a part of this event to contribute your novel research ideas.

​Proteomics market analysis has its advancement in case of Proteomics equipment’s & technologies this has made enormous progress in past few years, & according to the Market Research, value of proteomics market was $9.3 billion in 2012, & is expected to reach 21.63$ billion by 2018, at a CAGR of 15.1%. Europe accounts for the second-largest share in the world wide proteomics market, in which Spain is one of the leading contributing states. Valencia is considered to be a hot spot for different researches which are carried out in the field of Proteomics. Proteomics attribute to the study of proteomes, but is also used to characterize the techniques used to determine the complete set of proteins of an organism or system, such as protein purification & mass spectrometry.

Proteomics is a developing field that has been deeply enabled by the human genome project. Proteins are also the products of genes, the machinery of the cells within our bodies. When genes are disturbed, the proteins are also effected. When pathogens infect, causing disease these proteins play a major role in signaling the presence & ridding us of these invaders. Almost in each and every process that occurs in our cells from the metabolization of simple sugar to the distribution of cells is dependent on proteins for smooth operation. In general, proteomics seeks to disclose and quantify as many proteins as possible.

征稿信息

重要日期

2017-04-17
初稿截稿日期

征稿范围

Track 1:Protein Expression & Analysis

 

  • Track 1-1Protein expression

  • Track 1-2Protein analysis

  • Track 1-3Protein characterization

  • Track 1-4Protein profiling

  • Track 1-5Protein identification

  • Track 1-6Protein interaction

  • Track 1-7Protein Biochemistry

  • Track 1-8Functional proteomics

  • Track 1-9Gel-free & based proteomics techniques

Track 2:Proteome Database

 

  • Track 2-1Plasma protein database

  • Track 2-2Human protein database

  • Track 2-3Yeast protein database

  • Track 2-4Plant protein database

Track 3:Mass Spectrometry Proteomics

 

  • Track 3-1Mass spectrometry based proteomics

  • Track 3-2Over expression and purification of the proteins

  • Track 3-3Protein identification and validation

  • Track 3-4Multidimensional protein identification technology – MudPIT

  • Track 3-5Liquid chromatography mass spectrometry (LC-MS)

  • Track 3-6Electrospray ionization mass spectrometry (ESI-MS)

  • Track 3-7Matrix-assisted laser desorption (MALDI-TOF-MS)

  • Track 3-8Computational methods of mass spectrometry in proteomics

  • Track 3-9Analysis of protein and proteome by mass spectrometry

  • Track 3-10Mass spectrometry based quantitative proteomics

  • Track 3-11Mass spectrometry data analysis in proteomics

  • Track 3-12Molecular imaging by mass spectrometry

Track 4:Proteomics Discovery & Function

 

  • Track 4-1Annotation, visualization, integrated discovery

  • Track 4-2Functional organization in yeast proteome

  • Track 4-3Proteomics approaches to identify biomarkers

  • Track 4-4Microarrays approaches in proteomics

  • Track 4-5Molecular and cellular proteomics

  • Track 4-6Biomarkers of bio fluids

  • Track 4-7Global analysis of protein localization

  • Track 4-8Structure and function of actin binding proteins

Track 5:Analytical Proteomics & Genomics

 

  • Track 5-1Protein sequence analysis

  • Track 5-2Analysis of DNA polymorphism data

  • Track 5-3Advanced computational genomic analysis

  • Track 5-4RNA data processing by transcriptomics

  • Track 5-5Structural biology and biophysics

  • Track 5-6Array-based analytical proteomics

  • Track 5-7Glycoproteomics & phosphoproteomics

Track 6:Protein Biochemistry

 

  • Track 6-1Molecular biochemistry

  • Track 6-2Analytical biochemistry

  • Track 6-3Clinical biochemistry

  • Track 6-4Medical biochemistry

  • Track 6-5Structural biochemistry

  • Track 6-6Nano biochemistry

  • Track 6-7Nutritional biochemistry

  • Track 6-8Agricultural biochemistry

  • Track 6-9Lipids biochemistry


Track 7:Personalized Medicine In Proteomics

  • Track 7-1Pharmacoproteomics and precision medicine

  • Track 7-2Clinical applications of precision medicine

  • Track 7-3Precision medicine for mental disorders

  • Track 7-4Advanced biomarkers for precision medicine

  • Track 7-5Biomarker analytics for translational research

  • Track 7-6Molecular biological profiling

Track 8:Cardiovascular Proteomics

  • Track 8-1Cardiovascular proteome biology

  • Track 8-2Cardiovascular prevention

  • Track 8-3Cardiovascular diseases

  • Track 8-4Cardiac gene expression

  • Track 8-5Haematological proteomics

  • Track 8-6Applications of cardiovascular proteomics

  • Track 8-7Cardiovascular medicine

Track 9:Proteomics & Computational Biology

  • Track 9-1Plant systems biology

  • Track 9-2Functional genomics

  • Track 9-3Data integration pathway analysis

  • Track 9-4Data mining and data analysis

  • Track 9-5Medical systems biology

  • Track 9-6Signalling and systems biology

  • Track 9-7Network biology- methods and applications

Track 10:Proteomics for Bioinformatics

  • Track 10-1Evolutionary bioinformatics

  • Track 10-2Structural bioinformatics

  • Track 10-3Next generation sequencing

  • Track 10-4Web services in bioinformatics

  • Track 10-5Programming languages in bioinformatics

  • Track 10-6High performance computing in bioinformatics

  • Track 10-7Pattern recognition, clustering & classification

  • Track 10-8Bayesian inference for gene expression & proteomics

Track 11:Plant Proteomics

  • Track 11-1Gel-free & based proteomics techniques

  • Track 11-2Plant genomics & proteomics

  • Track 11-3Plant growth & development

  • Track 11-4Environmental proteomics

  • Track 11-5Food & plant proteomics

  • Track 11-6Animal proteomics

Track 12:Food & Nutritional Proteomics

  • Track 12-1Proteomics of genetically modified crops

  • Track 12-2Proteomics in nutrition research

  • Track 12-3Dietary metabolites and cellular metabolism

  • Track 12-4Nutrigenomics and plant functional genomics

  • Track 12-5Food safety and contamination assessment using proteomics

  • Track 12-6Applications of proteomics to food processing

Track 13:Cancer & Clinical proteomics

  • Track 13-1Cancer biomarker development

  • Track 13-2Clinical applications of proteomics

  • Track 13-3Proteomics in cell biology and disease mechanisms

  • Track 13-4Protein biomarker discovery and delivery

  • Track 13-5Renal and urinary proteomics

  • Track 13-6Proteomics of microbial pathogens

  • Track 13-7Proteomics for mechanistic insight into cancer

  • Track 13-8Proteomics in development of anti-cancer therapeutics

Track 14:Immunoproteomics

  • Track 14-1Computational immunology

  • Track 14-2Systems immunology

  • Track 14-3Epigenetics of trained innate immunity

  • Track 14-4Applied immunology and immunotherapy

  • Track 14-5Application of proteomics in autoimmune diseases

Track 15:Protein Engineering & Molecular Design

  • Track 15-1Genetic, enzyme & antibody engineering

  • Track 15-2Chemistry on drug discovery

  • Track 15-3Molecular docking studies

  • Track 15-4Molecular dynamics & mechanics

  • Track 15-5Genetic function approximation to QSAR

  • Track 15-6Protein phosphatases & folding in the cell

  • Track 15-7Protein-protein interactions

  • Track 15-8Protein arrays, biochips and proteomics

  • Track 15-9Therapeutic protein analysis

  • Track 15-10Targeted drug delivery and gene therapy

Track 16:Neuroproteomics & Neurometabolomics

  • Track 16-1Proteomics in nephrology

  • Track 16-2Neurological disorders

  • Track 16-3Translational neuroimmunology

  • Track 16-4Proteomics in clinical neurosciences

  • Track 16-5Proteomics studies in nerological diseases

  • Track 16-6Proteomic analysis of neural epigenetic mechanisms

Track 17:Integrating Transcriptomics & Proteomics

  • Track 17-1Transcriptomics & proteomics in microorganisms

  • Track 17-2Epigenetics

  • Track 17-3Single cell transcriptomics

  • Track 17-4Transcriptome analysis & gene expression

  • Track 17-5Transcriptomics & proteomics in microorganisms

Track 18:Proteomics Technologies

  • Track 18-1Biophysics in proteomics research

  • Track 18-2Post translational modifications

  • Track 18-3Protein identification & profiling

  • Track 18-4Targeted proteomics

  • Track 18-5Chemical biology & proteomics

  • Track 18-6Top-down proteomics

  • Track 18-7Tissue proteomics

  • Track 18-8Proteomics for stem cell medicine

Track 19:Biomedical Sciences In Proteomics

  • Track 19-1Systems biomedicine

  • Track 19-2Bioimaging & bioengineering

  • Track 19-3Molecular and cellular principles

  • Track 19-4Biochemical reactions and enzyme kinetics

  • Track 19-5Functional disulfide bonds in health and disease

Track 20:Proteomics Case Study

  • Track 20-1Diabetes case reports

  • Track 20-2Enzyme based proteomics

  • Track 20-3Auto-immune disorder case report

  • Track 20-4Neurophysiological proteomics case report

  • Track 20-5Cancer case study

Track 21:Business Trends In Proteomics

  • Track 21-1Markets trends in biochips and microfluidic chips

  • Track 21-2Big data and corporate evolution

  • Track 21-3Expression proteomics and bioinformatics market

Track 22:Machine Learning in Bioinformatics

 

  • Track 22-1Bioinformatics Tools & Software

  • Track 22-2Pattern recognition and machine learning

  • Track 22-3Practical machine learning tools and techniques

  • Track 22-4Machine learning in prediction of protein secondary structure

  • Track 22-5Support vector machines

留言
验证码 看不清楚,更换一张
全部留言
重要日期
  • 会议日期

    05月22日

    2017

    05月24日

    2017

  • 04月17日 2017

    初稿截稿日期

  • 05月24日 2017

    注册截止日期

移动端
在手机上打开
小程序
打开微信小程序
客服
扫码或点此咨询